These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17595778

  • 1. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Hsieh YJ, Liu RS, Hwu L, Ke CC, Wang FH, Wang HE, Chen FD.
    Anticancer Res; 2007; 27(3B):1571-9. PubMed ID: 17595778
    [Abstract] [Full Text] [Related]

  • 2. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 5. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H, Tachibana I, Tanio Y, Kishimoto T.
    Cancer Res; 1999 Oct 01; 59(19):4906-11. PubMed ID: 10519403
    [Abstract] [Full Text] [Related]

  • 6. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
    Hsieh YJ, Chen FD, Ke CC, Wang HE, Huang CJ, Hou MF, Lin KP, Gelovani JG, Liu RS.
    Mol Imaging Biol; 2012 Aug 01; 14(4):452-61. PubMed ID: 21796480
    [Abstract] [Full Text] [Related]

  • 7. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y, Zhang YD, Peng J, Yan HX, Xue D, Wu K, Zhou L, Hang SW, Zhao JF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May 01; 25(5):437-9. PubMed ID: 19426602
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 01; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 9. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
    Kawashita Y, Ohtsuru A, Miki F, Kuroda H, Morishita M, Kaneda Y, Hatsushiba K, Kanematsu T, Yamashita S.
    Gene Ther; 2005 Nov 01; 12(22):1633-9. PubMed ID: 16079887
    [Abstract] [Full Text] [Related]

  • 10. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Biochem Biophys Res Commun; 2001 Oct 05; 287(4):1034-40. PubMed ID: 11573968
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN, Huang WM, Harris MP, Machemer T, Maneval DC, Gregory RJ.
    Cancer Gene Ther; 1995 Sep 05; 2(3):191-7. PubMed ID: 8528962
    [Abstract] [Full Text] [Related]

  • 12. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Gene Ther; 1999 Apr 05; 6(4):465-70. PubMed ID: 10476206
    [Abstract] [Full Text] [Related]

  • 13. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK, Yang DH, Tang SH, Huang W, Lu XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):106-10. PubMed ID: 16620715
    [Abstract] [Full Text] [Related]

  • 14. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ, Huang R, Kuang AR.
    Cancer Invest; 2009 Jul 10; 27(6):673-81. PubMed ID: 19241193
    [Abstract] [Full Text] [Related]

  • 15. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 10; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 16. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 10; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 17. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS, Hsieh YJ, Ke CC, Chen FD, Hwu L, Wang FH, Hwang JJ, Chi CW, Lee CH, Yeh SH.
    Anticancer Res; 2009 Jan 10; 29(1):211-21. PubMed ID: 19331152
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD.
    Gene Ther; 2006 Feb 10; 13(3):206-15. PubMed ID: 16307003
    [Abstract] [Full Text] [Related]

  • 19. [Delivery of "suicide" thymidine kinase gene of herpes virus in the complex with cationic peptide into human hepatoma cells in vitro].
    Ignatovich IA, Dizhe EB, Akif'ev BN, Burov SV, Boiarchuk EA, Perevozchikov AP.
    Tsitologiia; 2002 Feb 10; 44(5):455-62. PubMed ID: 14696255
    [Abstract] [Full Text] [Related]

  • 20. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H, Ohtsuru A, Braiden V, Iwamatsu M, Miki F, Kawashita Y, Mizuta Y, Kaneda Y, Kohno S, Yamashita S.
    Oncol Rep; 2006 Mar 10; 15(3):629-35. PubMed ID: 16465423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.